आर्थिक इवेंट और अनुयायी लेखकों द्वारा सामग्री के लिए
अलर्ट बनाने के लिए साइन अप करें
निशुल्क साइन अप पहले से ही एक खाता है? साइन इन
कोट्स
सभी इंस्ट्रूमेंट के प्रकार
- सभी इंस्ट्रूमेंट के प्रकार
- सूचकांक
- इक्विटीज
- ETFs
- फंड
- कमोडिटीज
- मुद्रा
- क्रिप्टो
- बांड्स
- प्रमाण पत्र
कृपया अन्य खोज का प्रयास करें
🔥 हमारी एआई-चयनित स्टॉक स्ट्रेटेजी, टेक टाइटन्स, मई में अब तक +7.1% ऊपर है। स्टॉक्स में तेज़ी होने पर लाभ उठाएं। 40% की छूट क्लेम करें
Virtus KAR Health Sciences Fund Class A (RAGHX)
पोर्टफोलियो में जोड़ेंं/इससे हटाएँ
पोर्टफोलियो में जोड़ें
30.83
+0.04
+0.13%
- मॉर्निंगस्टार रेटिंग:
- कुल संपतियां: 134.92M
AllianzGI Health Sciences A
30.83
+0.04
+0.13%
- अवलोकन
- प्रोफाइल
- ऐतिहासिक डेटा
- होल्डिंग्स
RAGHX अवलोकन
इस पेज पर आपको Virtus KAR Health Sciences Fund Class A की गहरी प्रोफाइल मिलेगी। अन्य जानकारी में RAGHX के प्रमुख प्रबंधन, कुल सम्पत्तियों, निवेश रणनीति एवं संपर्क जानकारी के बारे में जानें।
संपर्क जानकारी
शीर्ष अधिकारी
| नाम | शीर्षक | पहले | जब तक |
|---|---|---|---|
| Jon K Christensen | Portfolio Manager | 2022 | अभी |
| जीवनी | Jon Christensen, CFA, Portfolio Manager | Mr. Christensen is a Portfolio Manager and a Senior Research Analyst with primary research responsibilities for the small and mid-capitalization health-care sector. Before joining Kayne Anderson Rudnick in 2001, Mr. Christensen was a Portfolio Manager and Senior Research Analyst for Doheny Asset Management and has approximately 18 years of equity research experience. He earned a B.S. in Mathematics/Applied Science from the University of California, Los Angeles, and an M.B.A. from the California State University, Long Beach. Mr. Christensen is a Chartered Financial Analyst charterholder. | ||
| Chris Armbruster | Portfolio Manager + Senior Research Analyst | 2022 | अभी |
| जीवनी | Mr. Armbruster is a Portfolio Manager and Research Analyst at KAR with primary research responsibilities for the large-capitalization consumer discretionary, health care, and information technology sectors. Before joining Kayne Anderson Rudnick in 2013, Mr. Armbruster worked at B. Riley & Co. as an associate analyst covering special situations, and at Al Frank Asset Management as a vice president in equity research. | ||
| Christopher Chin | - | 2020 | 2022 |
| Peter Pirsch | Senior Portfolio Manager | 2018 | 2022 |
| जीवनी | Mr. Pirsch is a senior portfolio manager, a senior analyst and a director with Allianz Global Investors, which he joined in 2018. He has management and research responsibilities for the Health Care team. Mr. Pirsch has 20 years of investment-industry experience. He previously worked at Aptigon Capital, Visium Asset Management, Surveyor Capital, Fred Alger Management and C.R. Bard. Before that, Mr. Pirsch was an associate director at UBS Investment Bank and an analyst at Wells Fargo. He has a B.A. in economics and international relations from Bucknell University, and an M.B.A. with a certificate in health sector management from Duke University, Fuqua School of Business. Mr. Pirsch is a CFA charterholder. | ||
| Bret Jones | Portfolio Manager | 2018 | 2019 |
| जीवनी | Mr. Jones is a portfolio manager, senior analyst and a director with Allianz Global Investors, which he joined in 2018. He is a member of the Health Care team covering health care services companies.He was previously a senior health care analyst at Pura Vida Investments; Oppenheimer; Brean Murray, Carret and Leerink Swann. Before that, Mr. Jones was an equity research associate at SG Cowen. He has a B.S., magna cum laude, in finance from Florida State University, and an M.B.A. from Kelley School of Business, Indiana University. Mr. Jones is a CFA charterholder. | ||
| John R. Schroer | Portfolio Manager | 2014 | 2018 |
| जीवनी | Mr. Schroer, CFA, is a portfolio manager and a director with Allianz Global Investors, which he joined in 2014. He is the sector head of the Health Care team. He was previously the president of Schroer Capital, L.P.; an equity analyst with HealthCor Management, L.P.; a managing member and portfolio manager for ITROS Capital Management, LLC; a global partner, senior vice president, and portfolio manager for INVESCO; and an analyst for Trust Company of the West. Mr. Schroer has a B.S. in history and international relations and an M.B.A. in finance from the University of Wisconsin. | ||
| Michael Dauchot | Portfolio Manager | 2005 | 2018 |
| जीवनी | Dr. Dauchot, CFA, is a portfolio manager, a senior research analyst and a director with Allianz Global Investors, which he joined in 1999. He is a member of the Health Care team, focusing on medical technology, life-science tools and diagnostics. He previously worked at Pequot Capital Management and BancBoston Robertson Stephens. Dr. Dauchot has a degree in chemistry from Case Western Reserve University, an M.B.A. from the Kellogg School of Management at Northwestern University and an M.D. from the University of Cincinnati College of Medicine. | ||
| Paul A. Wagner | Senior Research Analyst | 2008 | 2014 |
| जीवनी | Mr. Wagner, CFA, is a portfolio manager, a senior research analyst and a director with Allianz Global Investors, which he joined in 2006. He has biotechnology responsibilities for the US Health Care team and has 14 years of investment-industry experience. Mr. Wagner previously worked at PDL BioPharma in corporate and business development, and was a vice president and senior equity-research analyst in the biotechnology sector at Lehman Brothers. He has a B.S. in chemistry from the University of Wisconsin and a Ph.D. in chemistry from the California Institute of Technology. | ||
| Ken H. Tsuboi | Health Care team | 2007 | 2013 |
| जीवनी | Ken joined RCM in 1996, beginning his work on the Health Care team in 2000. Ken covers international healthcare companies, analyzing stocks for recommendation to the international portfolio management team. Previously, Mr. Tsuboi was an Asset Backed Analyst for RCM's fixed income team, where he was responsible for the implementation, strategy and evaluation of all asset- backed products. Prior to RCM, Ken was a Senior Portfolio Strategist at Payden & Rygel. | ||
| Dan Hunt | Member | 2008 | 2013 |
| जीवनी | Dan was responsible for proprietary and client-directed investment idea generation across sectors, with an emphasis on healthcare. He was appointed (as the youngest member) to SG Cowen’s seven-person Investment Policy Committee. Prior to joining SG Cowen, Dan worked for Thomson Financial/Carson in New York as a Senior Associate within Capital Markets Intelligence. Dan holds the Chartered Financial Analyst designation. | ||
Virtus KAR Health Sciences Fund Class A के बारे में अपने विचार लिखें
क्या आप सच में इस चार्ट को डिलीट करना चाहते हैं?
डिलीट करें रद्द करें
सभी सलंग्न चार्ट को नए चार्ट से बदलें?
बदलें रद्द करें
टिप्पणी दिशा निर्देश
टिप्पणी में चार्ट जोड़ें
ब्लॉक की पुष्टी करें
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
इस टिपण्णी को दर्ज करें
मुझे लगता है कि यह टिपण्णी:
टिप्पणी ध्वजांकित
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है